313 related articles for article (PubMed ID: 1456888)
1. Studies on processing, particle formation, and immunogenicity of the HIV-1 gag gene product: a possible component of a HIV vaccine.
Wagner R; Fliessbach H; Wanner G; Motz M; Niedrig M; Deby G; von Brunn A; Wolf H
Arch Virol; 1992; 127(1-4):117-37. PubMed ID: 1456888
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of cellular and humoral immune responses to human immunodeficiency virus type 1 Gag and Pol by a G/P-92 fusion protein expressing highly immunogenic Gag p17/p24 and Pol p51 antigens.
Kmieciak D; Bolesta E; Naito T; Gzyl J; Kaneko Y; Kozbor D
J Hum Virol; 2001; 4(6):306-16. PubMed ID: 12082397
[TBL] [Abstract][Full Text] [Related]
3. Development of HIV/AIDS vaccine using chimeric gag-env virus-like particles.
Kang CY; Luo L; Wainberg MA; Li Y
Biol Chem; 1999 Mar; 380(3):353-64. PubMed ID: 10223338
[TBL] [Abstract][Full Text] [Related]
4. Identification of protein intermediates in the processing of the p55 HIV-1 gag precursor in cells infected with recombinant vaccinia virus.
Gowda SD; Stein BS; Engleman EG
J Biol Chem; 1989 May; 264(15):8459-62. PubMed ID: 2785991
[TBL] [Abstract][Full Text] [Related]
5. Morphogenesis of recombinant HIV-2 gag core particles.
Voss G; Kirchhoff F; Nick S; Moosmayer D; Gelderblom H; Hunsmann G
Virus Res; 1992 Jul; 24(2):197-210. PubMed ID: 1529643
[TBL] [Abstract][Full Text] [Related]
6. Maturation of human immunodeficiency virus particles assembled from the gag precursor protein requires in situ processing by gag-pol protease.
Ross EK; Fuerst TR; Orenstein JM; O'Neill T; Martin MA; Venkatesan S
AIDS Res Hum Retroviruses; 1991 May; 7(5):475-83. PubMed ID: 1873082
[TBL] [Abstract][Full Text] [Related]
7. Expression and immunogenicity of human immunodeficiency virus type 1 Gag expressed by a replication-competent rhabdovirus-based vaccine vector.
McGettigan JP; Sarma S; Orenstein JM; Pomerantz RJ; Schnell MJ
J Virol; 2001 Sep; 75(18):8724-32. PubMed ID: 11507217
[TBL] [Abstract][Full Text] [Related]
8. Cell line-dependent release of HIV-like gag particles after infection of mammalian cells with recombinant vaccinia viruses.
Dru A; Ludosky MA; Cartaud J; Beaud G
AIDS Res Hum Retroviruses; 1994 Apr; 10(4):383-90. PubMed ID: 7520722
[TBL] [Abstract][Full Text] [Related]
9. Identification of human immunodeficiency virus type 1 Gag protein domains essential to membrane binding and particle assembly.
Spearman P; Wang JJ; Vander Heyden N; Ratner L
J Virol; 1994 May; 68(5):3232-42. PubMed ID: 8151785
[TBL] [Abstract][Full Text] [Related]
10. Expression of gag precursor protein and secretion of virus-like gag particles of HIV-2 from recombinant baculovirus-infected insect cells.
Luo L; Li Y; Kang CY
Virology; 1990 Dec; 179(2):874-80. PubMed ID: 2238477
[TBL] [Abstract][Full Text] [Related]
11. Increased expression and immunogenicity of sequence-modified human immunodeficiency virus type 1 gag gene.
zur Megede J; Chen MC; Doe B; Schaefer M; Greer CE; Selby M; Otten GR; Barnett SW
J Virol; 2000 Mar; 74(6):2628-35. PubMed ID: 10684277
[TBL] [Abstract][Full Text] [Related]
12. Analysis of HIV particle formation using transient expression of subviral constructs in mammalian cells.
Mergener K; Fäcke M; Welker R; Brinkmann V; Gelderblom HR; Kräusslich HG
Virology; 1992 Jan; 186(1):25-39. PubMed ID: 1727601
[TBL] [Abstract][Full Text] [Related]
13. Human immunodeficiency virus-like particles produced by a vaccinia virus expression vector.
Karacostas V; Nagashima K; Gonda MA; Moss B
Proc Natl Acad Sci U S A; 1989 Nov; 86(22):8964-7. PubMed ID: 2479031
[TBL] [Abstract][Full Text] [Related]
14. Role of the gag and pol genes of human immunodeficiency virus in the morphogenesis and maturation of retrovirus-like particles expressed by recombinant vaccinia virus: an ultrastructural study.
Hoshikawa N; Kojima A; Yasuda A; Takayashiki E; Masuko S; Chiba J; Sata T; Kurata T
J Gen Virol; 1991 Oct; 72 ( Pt 10)():2509-17. PubMed ID: 1919528
[TBL] [Abstract][Full Text] [Related]
15. [Interaction of gag polyprotein-precursors p55 and p48 with p160gag-pol during formation of virus-like particles of HIV-1 with recombinant strains of vaccinia virus].
Iordanskiĭ SN; Lideman LF; Chikova AK; Gibadulin RA
Vopr Virusol; 1997; 42(5):205-8. PubMed ID: 9424843
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of the HIV-1 gag-pol polyprotein results in intracellular activation of HIV-1 protease and inhibition of assembly and budding of virus-like particles.
Karacostas V; Wolffe EJ; Nagashima K; Gonda MA; Moss B
Virology; 1993 Apr; 193(2):661-71. PubMed ID: 7681610
[TBL] [Abstract][Full Text] [Related]
17. Production of human immunodeficiency virus (HIV)-like particles from cells infected with recombinant vaccinia viruses carrying the gag gene of HIV.
Shioda T; Shibuta H
Virology; 1990 Mar; 175(1):139-48. PubMed ID: 1689917
[TBL] [Abstract][Full Text] [Related]
18. Assembly and extracellular release of chimeric HIV-1 Pr55gag retrovirus-like particles.
Wagner R; Deml L; Fliessbach H; Wanner G; Wolf H
Virology; 1994 Apr; 200(1):162-75. PubMed ID: 7510434
[TBL] [Abstract][Full Text] [Related]
19. Morphogenic capabilities of human immunodeficiency virus type 1 gag and gag-pol proteins in insect cells.
Hughes BP; Booth TF; Belyaev AS; McIlroy D; Jowett J; Roy P
Virology; 1993 Mar; 193(1):242-55. PubMed ID: 8438569
[TBL] [Abstract][Full Text] [Related]
20. Chimeric gag-V3 virus-like particles of human immunodeficiency virus induce virus-neutralizing antibodies.
Luo L; Li Y; Cannon PM; Kim S; Kang CY
Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10527-31. PubMed ID: 1438241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
